About Concept Life Sciences
Concept Life Sciences is a company based in Manchester (United Kingdom) founded in 2014 by Michael John Fort was acquired by Limerston Capital Partners in April 2023. It operates as a Professional Services. Concept Life Sciences has completed 4 acquisitions, including Aquila BioMedical, Charnwood Discovery and Concept Life Sciences. Concept Life Sciences offers products and services including Integrated Drug Discovery, ADMET & DMPK, Biology Services, and Chemistry Services. Concept Life Sciences operates in a competitive market with competitors including Evotec, Crown Bioscience, Alloy Therapeutics, Domainex and NIH, among others.
- Headquarter Manchester, United Kingdom
- Founders Michael John Fort
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Concept Life Sciences
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Spectris
& 2 more
-
Employee Count
Not available
-
Investments & Acquisitions
Aquila BioMedical
& 3 more
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Concept Life Sciences
Concept Life Sciences offers a comprehensive portfolio of products and services, including Integrated Drug Discovery, ADMET & DMPK, Biology Services, and Chemistry Services.
Drug discovery services are provided from concept to clinic.
Drug candidate properties are analyzed in vitro and vivo.
Biological targets are validated and mechanisms are studied.
Synthetic and medicinal chemistry solutions are expertly provided.
People of Concept Life Sciences
Unlock access to complete
Funding Insights of Concept Life Sciences
Investors in Concept Life Sciences
Concept Life Sciences has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Spectris, Equistone Partners Europe and Limerston Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A mid-market private equity firm based in Europe is operated.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Process monitoring and optimisation services are provided for multiple industries.
|
Locked | Locked | Locked |
Investor details for Concept Life Sciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Concept Life Sciences
Concept Life Sciences has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include Aquila BioMedical, Charnwood Discovery and Concept Life Sciences.
Investment portfolio details for Concept Life Sciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Preclinical services in immunology, regeneration, neuroscience, and histology are provided.
|
Locked | Locked | 2011 | Locked | |
|
Concept Life Sciences is engaged in drug discovery and development services.
|
Locked | Locked | 2006 | Locked | |
|
Outsourced drug discovery services support pharmaceutical and biotech clients.
|
Locked | Locked | 1998 | Locked |
Complete acquisition details for Concept Life Sciences
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Concept Life Sciences
Detailed financials for Concept Life Sciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Concept Life Sciences Comparisons
Peer comparison for Concept Life Sciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Concept Life Sciences
Concept Life Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Evotec, Crown Bioscience, Alloy Therapeutics, Domainex and NIH, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Drug discovery and development services are provided to biopharma sector.
|
|
| Locked | Locked | Locked |
Cancer and CVMD drugs are developed using PDX models.
|
|
| Locked | Locked | Locked |
Drug discovery services are provided for therapeutic development.
|
|
| Locked | Locked | Locked |
Drug discovery CRO company for epigenetic research and inflammatory diseases
|
|
| Locked | Locked | Locked |
Drug discovery services are provided to the biopharma sector.
|
|
| Locked | Locked | Locked |
Drug discovery and development research services are provided.
|
Detailed competitors of Concept Life Sciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Concept Life Sciences
Complete news archive for Concept Life Sciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Concept Life Sciences
Concept Life Sciences was founded in 2014.
Concept Life Sciences is headquartered in Manchester, United Kingdom. It is registered at Manchester, Greater Manchester, United Kingdom.
Karl Moss is the current CEO of Concept Life Sciences.
Concept Life Sciences is involved in providing integrated drug discovery and development services from concept to clinic. Services are offered across various modalities including small molecules, biologics, and cell gene therapies. The company is focused on therapeutic areas such as immuno-oncology, liver disease, oncology, neuroscience, and immunology. Solutions are provided for target validation, hit identification, lead optimization, and candidate selection. Comprehensive biology, chemistry, and ADMET DMPK services are delivered to accelerate drug development timelines for clients in the healthcare sector.
Concept Life Sciences's top competitors include Evotec, Crown Bioscience and NIH.
Concept Life Sciences offers Integrated Drug Discovery, ADMET & DMPK, Biology Services, and Chemistry Services.
Concept Life Sciences has made 4 acquisitions, including Aquila BioMedical, Charnwood Discovery, and Concept Life Sciences.
Concept Life Sciences has 3 investors. Key investors include Spectris, Equistone Partners Europe, and Limerston Capital Partners.